VeraSci
  • Who We Are
    • Leadership
    • Careers
    • Contact Us
  • Therapeutic Expertise
    • Dementia
    • Dermatology
    • Digital Therapeutics
    • Mood Disorders
    • Multiple Sclerosis
    • Parkinson’s Disease
    • Rare & Orphan Disorders
    • Schizophrenia
    • See All
  • What We Do
    • Consulting Services
    • Pathway eCOA
    • Placebo Response Mitigation
    • Endpoints & Assessments
    • Remote Clinical Trials
    • Trial Services
    • Translation & Cultural Adaptation
  • Resources
    • News
    • Events
    • Blog
    • VeraSci Innovation Lab
  • Contact Us
    • Submit an RFP
Select Page

The Endless Frontier? The Recent Upsurge of R&D Productivity in Pharmaceuticals

by Ashley Davis | Jul 23, 2019 | Publications and Articles

Classical analyses of pharmaceutical pipelines from 1990 to 2010 reported increasing attrition rates and duration of clinical trials, leading to a perception of a “productivity crisis” in this sector. However, in contrast, a more recent analysis of over 45,000...

Virtual reality assessment of functional capacity in the early course of schizophrenia

by Ashley Davis | Jun 27, 2019 | Publications and Articles

Computer-based virtual reality assessments of functional capacity have shown promise as a reliable and valid way to assess individuals with multi-episode schizophrenia. However, there has been little research utilizing this innovative approach with young patients who...

Linguistic and Cultural Adaptation of Cognitive Assessments in the TOMMORROW Trial

by Ashley Davis | Jun 25, 2019 | Case Study

How VeraSci supported authentic translation and cultural adaptation of neurocognitive assessments in a multinational, large scale, long-term clinical trial for delaying the onset of Mild Cognitive Impairment stage of Alzheimer’s Disease.

Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS)

by Ashley Davis | Jun 20, 2019 | Publications and Articles

The Schizophrenia Cognition Rating Scale (SCoRS) is a 20-item interview-based clinical assessment that evaluates cognitive deficits and the degree to which these deficits impair patients’ day-to-day functioning. It was originally developed in 2001 at Duke University...

Meeting the Needs Of A Landmark Trial

by Ashley Davis | Jun 5, 2019 | Case Study

How VeraSci effectively and efficiently provided support to a large scale, multinational, long-term clinical trial for pre-clinical phase Alzheimer’s Disease.
« Older Entries
Next Entries »

Recent Posts

  • Examining the Connection Between COVID-19 and Cognition
  • VeraSci Partners with ActiGraph to Expand the Use of Wearables in Clinical Trials
  • VeraSci Sees Continued Growth Despite COVID-19 Challenges Faced by Clinical Trials Industry

Archives

  • VeraSci
  • 3211 Shannon Rd., Suite 300
  • Durham, NC 27707 USA
  • +1.919.401.4642
  • info@verasci.com
  • Who We Are
  • Leadership
  • Careers
  • Contact Us
  • Therapeutic Expertise
  • Dementia & Related Disorders
  • Dermatology
  • Mood Disorders
  • Multiple Sclerosis
  • Parkinson’s Disease & Related Disorders
  • Rare & Orphan Disorders
  • Schizophrenia
  • What We Do
  • Consulting Services
  • Pathway eCOA
  • Endpoints & Assessments
  • Remote Clinical Trials
  • Trial Services
  • Translation & Cultural Adaptation
  • Resources
  • News
  • Events
  • Blog
Privacy Policy Ethics Policy
  • Linkedin
  • Twitter
  • RSS
  • Facebook
ISO 17100 certified ISO 17100 certified ISO 17100 certified
© 2021 Copyright VeraSci. All Rights Reserved.

Our website uses cookies to personalize content, save your preferences, and enhance your overall experience. If you click accept or continue to navigate our website, you agree to having those cookies set on your device. To learn more about adjusting your preferences please visit our Privacy Policy.  Accept  Reject

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Uncategorized

Undefined cookies are those that are being analyzed and have not been classified into a category as yet.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Save & Accept